RSS

clinical trial

The first patient has been enrolled by InterveXion in STAMPOUT — the first trial in methamphetamine users of the first-in-class anti-methamphetamine antibody IXT-m200 — the news of which Catalent Pharma Solutions has welcomed. more

News

The first European approval for a Phase II clinical trial with THN102 in Parkinson’s patients has been announced by biopharmaceutical company, Theranexus. more

News

Clinical-stage biotech company, Genoscience Pharma, has started administering GNS561 in a Phase I/IIa trial of patients with advanced liver cancer. more

News

A Phase II clinical trial has begun in the US to evaluate a new drug, GDC-0084, that targets the signalling pathway implicated in almost all (90%) of glioblastoma multiforme brain cancer cases. more

News